Quince Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.02M
on 2026-06-30, from 216K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-10 and 1-for-20 reverse splits; each bar's tip shows the count as filed.
Newest
S-3 of 2025-07-25. Not read yet. S-3 ↗
8 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
9.9 quarters
$116.0M on 2026-06-30 ÷ $11.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
Raised: 9 of its filings are not read yet.
Also on file: a 1-for-10 reverse split, 2026-04-10 8-K ↗